Company intelligence / Profile preview

NCIA

Seoul, Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

The National Clinical Investigation Agency (NCIA) is a South Korean contract research organization (CRO) that provides comprehensive clinical trial services to the pharmaceutical, biotechnology, and medical device industries. The company specializes in managing Phase I through Phase IV clinical trials, offering expertise in clinical monitoring, data management, biostatistics, and regulatory affairs. NCIA focuses on streamlining the drug development process for domestic and international clients seeking to conduct trials within the Asia-Pacific region. By leveraging its local regulatory knowledge and network of clinical sites, NCIA facilitates the efficient execution of clinical research projects.

Industry: Contract Research Organization

Beyond the preview

Go deeper on NCIA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NCIA.

Explore the full profile